YCYichi Chen

Yichi Chen

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Yichi Chen has a total of 25 co-authors. Here are the top co-authors by number of shared publications:

  • Wen Cheng

    Department of Ultrasound Harbin Medical University Cancer Hospital Harbin China

    3 shared publications
  • Bolin Wu

    Department of Ultrasound Harbin Medical University Cancer Hospital Harbin Heilongjiang People's Republic of China

    2 shared publications
  • Bolin Wu

    Department of Ultrasound, Harbin Medical University Cancer Hospital, Harbin Medical University Cancer Hospital, No. 150, Haping Road, Nangang District, Harbin, 150081, People's Republic of China, Harbin, Heilongjiang, 150081, CHINA

    1 shared publication
  • Chen Guan

    Department of Nephrology The Affiliated Hospital of Qingdao University Qingdao China

    1 shared publication
  • Chunhua Han

    Department of Clinical Laboratory The Affiliated Hospital of Qingdao University Qingdao China

    1 shared publication
  • Chunyue Wang

    Department of Ultrasound Harbin Medical University Cancer Hospital Harbin Heilongjiang People's Republic of China

    1 shared publication

Latest Publications

  • Lipopolysaccharide‐Triggered Self‐Assembling Peptide Nanotraps for Coordinated Capture‐Killing‐Endotoxin Neutralization in Complicated Urinary Tract Infection

    by Zhuo Song, Ningxin Zhang, Jiaxiang Zhou, Chen Guan, Ya Liu, Tianyang Li, Haiyan Yu, Chunhua Han, Wen Cheng, Bolin Wu, et al.

    Complicated urinary tract infections (cUTIs) caused by uropathogenic E. coli (UPEC) remain difficult to treat because multidrug resistance and continuous urinary washout jointly limit antibacterial efficacy and local drug retention. Here, a lipopolysaccharide (LPS)‐responsive supramolecular peptide conjugate, PpIX‐GFFVLK‐HWKAVNWLKPWT (PFFH), is developed to address this delivery–retention trade‐off through pathogen‐triggered structural adaptation. PFFH integrates an E. coli LPS‐binding motif, a β‐sheet‐forming self‐assembly segment, and a PpIX sonosensitizer. It remains dispersed during delivery but transforms into peribacterial nanofibrous networks upon LPS recognition, promoting bacterial trapping and positioning PpIX near the bacterial interface for localized sonodynamic ROS activity. PFFH retains LPS‐responsive assembly and antibacterial activity under urine‐mimicking conditions and effectively kills reference and multidrug‐resistant UPEC. The same LPS‐binding motif also sequesters bacteriolysis‐derived endotoxin and attenuates inflammatory activation. In a mouse cUTI model, PFFH shows prolonged retention at infected urinary sites, reduces bacterial burdens, and alleviates inflammatory injury. Thus, PFFH extends LPS‐triggered structural adaptation beyond bacterial trapping to resolve the delivery–retention trade‐off in cUTIs, while coupling peribacterial sonodynamic activity with endotoxin regulation in a single molecular platform, thereby establishing a disease‐adapted supramolecular strategy for drug‐resistant cUTIs.

  • Open Access

    Defect‐Engineered BiO 2‐X Nanosheets Mediate Sono‐Thermomechanical ECM Remodeling for Hepatocellular Carcinoma Immunotherapy

    by Huimin Tian, Shen Zhang, Bolin Wu, Yichi Chen, Haitao Shang, Haoyan Tan, Chunyue Wang, Weichen Xu, Huixiong Xu, Haohao Yin, et al.

    Immune checkpoint blockade for hepatocellular carcinoma (HCC) is frequently limited by the extracellular matrix (ECM). Through transcriptomic profiling, we identify that acquired anti‐PD‐1 resistance in HCC models is closely associated with prominent Fibronectin 1 (Fn1) upregulation within the tumor microenvironment. To address these interconnected physical and biological barriers, we developed an ultrasound‐responsive nanoplatform utilizing oxygen‐defect‐abundant 2D BiO 2‐X nanosheets loaded with Fn1‐targeted small interfering RNA (BiO 2‐X /siFn1). Introducing oxygen vacancies into ultrathin BiO 2‐X alters its band structure, enhancing sono‐thermomechanical energy conversion under localized acoustic excitation. This synchronized sono‐thermomechanical effect physically remodels the dense collagen matrix, enhancing intratumoral permeation and spatially facilitating immune cell infiltration without relying on extreme hyperthermia. Concurrently, sonothermal‐sonomechanical synergistic enhancement of intracellular delivery of siFn1 efficiently downregulates Fn1 expression. This genetic intervention deprives detached tumor cells of integrin‐mediated focal adhesion survival signals, resensitizing them to anoikis and effectively suppressing ECM‐associated pulmonary metastasis. The BiO 2‐X /siFn1 nanoplatform significantly increased the recruitment of CD8 + T cells in tumors and restored the therapeutic effect of inhibiting PD‐1 in HCC by combining macroscopic physical ECM remodeling with precise molecular blocking of mechanical conduction pathways. This defect‐engineered sonosensitization strategy modulates the solid tumor microenvironment and overcomes mechanically induced immunotherapy resistance.

  • TAPP@NBs combined with GSNO to enhance the anti-liver cancer effect of sonodynamic therapy

    by Chunyue Wang, Xiaodong Wang, Fengjiao Chen, Huimin Tian, Yichi Chen, Bolin Wu, Wen Cheng

    Sonodynamic therapy (SDT) is a viable alternative to traditional photodynamic therapy owing to its ability to penetrate tissue. However, the therapeutic efficacy of a single SDT treatment is constrained by the prolonged hypoxia of the tumor, rendering SDT ineffective for treating disease. SDT was used in conjunction with nitric oxide (NO) gas in this study to induce apoptosis and ferroptosis in hepatocellular carcinoma (HCC) cells for treating cancer treatment. We synthesized 5,10,15,20-tetra (4-aminophenyl) porphyrin nanobubbles (TAPP@NBs) for the SDT treatment. S-nitroso glutathione (GSNO) was used as an NO gas donor. The in vitro anticancer effect of the combined treatment was examined using HepG2 and HUH7 hepatoma cell lines. Reactive oxygen species and NO were examined using 2,7-dichlorodihydrofluorescein diacetate and 3-amino,4-aminomethyl-2′,7′-difluorescein diacetate staining, respectively. Cell proliferation and apoptosis were analyzed using CCK-8 and flow cytometry, respectively. Ferroptosis was evidenced using glutathione and malondialdehyde assays. The cellular migratory capacity was assessed using a Transwell assay. TAPP@NBs can serve as a sonosensitizer for the SDT. GSNO serves as an NO donor under ultrasound and contributes to gas treatment, considerably increasing SDT efficacy. HCC cell proliferation and migration were considerably lower after combined SDT and NO gas therapy. Combined SDT and NO gas therapy induced apoptosis and ferroptosis in HCC cells. This paper describes a novel approach for optimizing tumor treatment.